Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new actos clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on actos
- Pioglitazone for Hepatic Steatosis in HIV/HCV Co-Infection
Status: Recruiting, Condition Summary: HIV; Hepatitis C; Liver Disease; Fatty Liver; Steatosis - A Pilot Study of Therapy With Pioglitazone Prior to HCV Treatment in HIV-1 and HCV Genotype 1-Infected Subjects With Ins...
Status: Recruiting, Condition Summary: HIV; Hepatitis C; Insulin Resistance; Hepatic Steatosis; Peg-Interferon and Ribavirin Treatment Failure - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
Status: Recruiting, Condition Summary: Hepatitis C, Chronic - A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
Status: Active, not recruiting, Condition Summary: Diabetes Mellitus, Type 2 - Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
Status: Recruiting, Condition Summary: Cystic Fibrosis; Anti Inflammatory Non-Steroidal; Neutrophils - Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
Status: Not yet recruiting, Condition Summary: Mild Cognitive Impairment - MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus
Status: Not yet recruiting, Condition Summary: Type 2 Diabetes Mellitus - Efficacy Study of Pioglitazone HCL on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.
Status: Recruiting, Condition Summary: Bone Metabolism - MK0431 Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus
Status: Completed, Condition Summary: Type 2 Diabetes Mellitus - Initial Combination With Pioglitazone Study
Status: Completed, Condition Summary: Type 2 Diabetes Mellitus - A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
Status: Recruiting, Condition Summary: Type 2 Diabetes Mellitus - Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone
Status: Recruiting, Condition Summary: Diabetes Mellitus, Type 2 - Efficacy and Safety Study of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes.
Status: Recruiting, Condition Summary: Diabetes Mellitus - Treating Nonalcoholic Steatohepatitis With Pioglitazone
Status: Active, not recruiting, Condition Summary: Hepatitis - Pioglitazone to Treat Fatty Liver in People With HIV Infection
Status: Recruiting, Condition Summary: HIV Infections; Hepatic Steatosis; Insulin Resistance - Pioglitazone Hydrochloride (Actos® (Registered Trademark)) to Treat Asthma
Status: Recruiting, Condition Summary: Asthma; Airway Inflammation; Airflow Obstruction; Airway Hyperactivity - Effect of Pioglitazone on Inflammation in Cystic Fibrosis
Status: Recruiting, Condition Summary: Cystic Fibrosis - Role of Pioglitazone and Berberine in the Treatment of Non-Alcoholic Fatty Liver Disease
Status: Recruiting, Condition Summary: Nonalcoholic Fatty Liver Disease - Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis
Status: Recruiting, Condition Summary: Amyotrophic Lateral Sclerosis - Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)
Status: Recruiting, Condition Summary: Metabolic Parameters and Liver Histology - Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation (PERISCOPE)
Status: Completed, Condition Summary: Diabetes Mellitus, Type 2; Coronary Artery Disease - Effect of Pioglitazone HCl on the Microcirculation in Type 2 Diabetes Patients Treated With Insulin
Status: Completed, Condition Summary: Type 2 Diabetes - A Study Evaluating Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
Status: Completed, Condition Summary: Diabetes Mellitus - Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
Status: Recruiting, Condition Summary: Depressive Disorder, Major; Metabolic Syndrome X - Pioglitazone Incretin Study
Status: Not yet recruiting, Condition Summary: Type 2 Diabetes - Retreatment of Chronic Hepatitis C Non-Responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone
Status: Suspended, Condition Summary: Chronic Hepatitis C - The Effect of SYR-322 Alone and in Combination With Pioglitazone on Post-Meal Blood Lipid Levels in Patients With Type 2 Diabetes
Status: Recruiting, Condition Summary: Diabetes Mellitus Type 2 - Exercise and Pioglitazone for HIV-Metabolic Syndromes
Status: Recruiting, Condition Summary: HIV Infections; Type 2 Diabetes; Obesity; HIV; AIDS; Cardiovascular Disease; Lipodystrophy - Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg
Status: Completed, Condition Summary: Healthy - Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg
Status: Completed, Condition Summary: Healthy